What is the fair value of Johnson & Johnson (NYSE-JNJ) stock?

The current fair value estimate for Johnson & Johnson (NYSE-JNJ) is $249.85. This implies an estimated downside of 7.5% versus the current market price.

Is Johnson & Johnson (NYSE-JNJ) undervalued or overvalued?

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 7.5% versus the current market price.

What is the analyst price target for NYSE-JNJ stock?

The available analyst price target for Johnson & Johnson (NYSE-JNJ) is $277.91. The analyst target implies estimated upside of 2.9%.

How is the financial health of Johnson & Johnson?

The current financial health read for Johnson & Johnson (NYSE-JNJ) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Johnson & Johnson's next earnings date?

The next earnings date currently listed for Johnson & Johnson (NYSE-JNJ) is October 13, 2026.

Does Johnson & Johnson (NYSE-JNJ) pay dividends?

Based on the current data, dividend yield is 2.0%.

What is the P/E ratio for Johnson & Johnson (NYSE-JNJ)?

The current P/E ratio listed for Johnson & Johnson (NYSE-JNJ) is 31.0x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of Johnson & Johnson?

The current market capitalization listed for Johnson & Johnson is 650.6 B.

What is the enterprise value of Johnson & Johnson?

The current enterprise value listed for Johnson & Johnson is 679.5 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Johnson & Johnson?

The ticker symbol for Johnson & Johnson is NYSE-JNJ, and the stock is listed on NYSE.

Where is Johnson & Johnson (NYSE-JNJ) listed?

Johnson & Johnson (NYSE-JNJ) is listed on NYSE.

What is the debt-to-total-capital ratio for Johnson & Johnson?

The current debt-to-total-capital ratio listed for Johnson & Johnson is 7.0%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Johnson & Johnson?

The free float listed for Johnson & Johnson is 99.8%. Free float helps investors understand how much of the share base is available for public trading.

Johnson & Johnson (JNJ) Fair Value & Stock Analysis

Johnson & Johnson (JNJ)

Johnson & Johnson is a healthcare company whose common stock is listed on the New York Stock Exchange under the symbol JNJ. Through its subsidiaries, the company is involved in researching, developing, manufacturing, and selling a broad range of healthcare products worldwide. Its operations are organized into two segments: Innovative Medicine and MedTech. The Innovative Medicine segment includes products used in areas such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism. The MedTech segment covers products and technologies used in surgery, orthopedics, cardiovascular care, and vision, including offerings for joint reconstruction, trauma, spine, sports injuries, minimally invasive procedures, breast aesthetics, contact lenses under the ACUVUE brand, and intraocular lenses under the TECNIS brand. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Dividend Yield	Next Earnings Date	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
NYSE-JNJ	$249.85	-7.5% Downside	Fair	$277.91	2.9% Upside	Fair	Good	2.0%	October 13, 2026	31.0x	7.7x	6.6x	650.6 B	679.5 B	7.0%	99.8%	7.5	60.0%	105.7%